---
figid: PMC6813749__kfz168f5
figtitle: Engineered cardiac tissues (ECTs) generated in Biowire II platform have
  canonical responses to compounds that affect contractility via physiologically relevant
  pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6813749
filename: kfz168f5.jpg
figlink: /pmc/articles/PMC6813749/figure/kfz168-F5/
number: F5
caption: Engineered cardiac tissues (ECTs) generated in Biowire II platform have canonical
  responses to compounds that affect contractility via physiologically relevant pathways.
  A, β-adrenergic/cAMP-mediated pathway and the L-type calcium channel. β-AR, β-adrenergic
  receptor; AC, adenylyl cyclase; PACAP, pituitary adenylate cyclase-activating peptide;
  cAMP, cyclic adenosine monophosphate; ATP, adenosine triphosphate; PDE, phosphodiesterase;
  PKA, protein kinase A; RYR2, ryanodine receptor; TnI, troponin-I; PLB, phospholamban.
  B, Gq-protein-coupled receptor signaling. ET-R, endothelin receptor; PLC, phospholipase
  C; PIP2, phosphatidylinositol 4, 5-bisphosphate; IP3, inositol 1, 4, 5-trisphosphate;
  DAG, diacylglycerol; PKC, protein kinase C. C, Modulation of proteins of the cardiac
  sarcomere.
papertitle: 'Engineered Cardiac Tissues Generated in the Biowire II: A Platform for
  Human-Based Drug Discovery.'
reftext: Nicole T Feric, et al. Toxicol Sci. 2019 Nov;172(1):89-97.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.547522
figid_alias: PMC6813749__F5
figtype: Figure
redirect_from: /figures/PMC6813749__F5
ndex: 0eae863b-df39-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6813749__kfz168f5.html
  '@type': Dataset
  description: Engineered cardiac tissues (ECTs) generated in Biowire II platform
    have canonical responses to compounds that affect contractility via physiologically
    relevant pathways. A, β-adrenergic/cAMP-mediated pathway and the L-type calcium
    channel. β-AR, β-adrenergic receptor; AC, adenylyl cyclase; PACAP, pituitary adenylate
    cyclase-activating peptide; cAMP, cyclic adenosine monophosphate; ATP, adenosine
    triphosphate; PDE, phosphodiesterase; PKA, protein kinase A; RYR2, ryanodine receptor;
    TnI, troponin-I; PLB, phospholamban. B, Gq-protein-coupled receptor signaling.
    ET-R, endothelin receptor; PLC, phospholipase C; PIP2, phosphatidylinositol 4,
    5-bisphosphate; IP3, inositol 1, 4, 5-trisphosphate; DAG, diacylglycerol; PKC,
    protein kinase C. C, Modulation of proteins of the cardiac sarcomere.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - par
  - para
  - par-6
  - ac
  - norpA
  - sl
  - Plc21C
  - Amph
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - ATPsynbeta
  - Atpalpha
  - amn
  - dnc
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - wupA
  - tn
  - thick
  - ca
  - NR1I2
  - JTB
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - APRT
  - MFAP1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ATP8A2
  - ADCYAP1
  - MZB1
  - ALDH7A1
  - PDE2A
  - PDE9A
  - PDE10A
  - PDE11A
  - PDE1A
  - PDE1B
  - PDE1C
  - PDE3A
  - PDE3B
  - PDE4A
  - PDE4B
  - PDE4C
  - PDE4D
  - PDE6A
  - PDE6B
  - PDE6C
  - PDE7A
  - PDE7B
  - PDE8A
  - PDE8B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - TRIM67
  - RYR2
  - PLN
  - PLB1
  - NT5E
  - WAS
  - Isoproterenol
  - Digoxin
  - AMP
  - ATP
  - Milrinone
  - FLP64176
  - Nifedipine
  - Ac
  - Levosimendan
---
